AU Pharma and Biotech Project, Program and Project Management Conference
MELBOURNE | 2025
International in-person conference filled with leading industry speakers.
key information
- Location: Melbourne, Australia
- Part of the PPM World Tour
- September 3-4, 2025
- 9:00 - 17:30 Local Time
What to expect
The AU Pharma and Biotech Project, Program and Portfolio Management Conference is the premier gathering for life sciences executives, portfolio leaders, and decision-makers in pharma, biotech, medtech, and diagnostics. As the Australian life sciences industry continues to evolve into a global leader in innovation, strategic portfolio management has never been more critical. This conference provides a deep dive into the latest trends, challenges, and best practices for optimizing portfolio performance, enhancing decision-making, and leveraging AI and digital transformation for business success.
Through insightful keynotes, case studies, panel discussions, and interactive roundtables, attendees will gain actionable strategies to drive innovation, balance risk, and execute high-impact portfolio decisions in an increasingly complex and competitive market.
Main takeaways
- Balancing Innovation, Risk, and Execution in Life Sciences Portfolios Discover how to navigate funding constraints and regulatory complexity while optimizing portfolio decision-making to drive growth and impact.
- From Overloaded to Optimized – Smarter Portfolio Prioritization: Learn how to master resource allocation, trade-offs, and scenario planning to maximize ROI and keep your projects on track in a competitive market.
- AI & Advanced Analytics – The Future of Project & Portfolio Management: Uncover how predictive modeling, real-time dashboards, and automation are transforming forecasting, risk assessment, and execution speed.
- Agility in PPM – Balancing Flexibility with Compliance: Explore how to implement hybrid and agile methodologies while ensuring regulatory adherence in an evolving pharma and biotech landscape.
- Scaling PPM from Strategy to Execution: Overcome execution bottlenecks and cross-functional misalignment to ensure seamless project delivery and business success.
Target audience breakdown:
- Portfolio & Program Managers – Responsible for overseeing multiple projects and ensuring strategic alignment.
- R&D Leaders – Managing innovation pipelines and investment decisions.
- Business & Corporate Strategy Executives – Driving long-term growth through effective portfolio prioritization.
- Financial & Investment Managers – Assessing ROI and risk mitigation in portfolio execution.
- Regulatory & Compliance Professionals – Navigating complex regulations while maintaining project agility.
- AI, Data Science & IT Leaders – Leveraging digital tools for predictive analytics and decision support.
- Clinical Development Executives – Streamlining clinical trial efficiency through better resource management.
- Mergers & Acquisitions (M&A) Specialists – Aligning portfolio strategy with corporate growth objectives.
- Innovation & Digital Transformation Leaders – Exploring AI, automation, and cutting-edge tools for PPM success.
Everything you need to know about this event in one spot.
Check out our event overview and agenda and discover this conference.
Event Partners
GOLD Sponsor
Planisware is a global provider of software solutions for project portfolio management. Planisware solutions are specifically designed to support product development, engineering and IT business processes. For more than 25 years, Planisware has been helping its customers to achieve strategic and innovative excellence, make valid business decisions and increase portfolio value. Today, over 1000 companies worldwide rely on Planisware products to manage their projects, resources and portfolios. Planisware Enterprise and Planisware Orchestra are two PPM software solutions listed as leaders in Gartner’s Magic Quadrant.
Silver Sponsor
Platflow is a comprehensive suite of cloud-based and on-premise software solutions (PLM, PPM, G2M) designed to empower enterprises in Life Science industries, including Pharma, Crop Science, Cosmetics, Biotech, Medical Devices, and CRO/CMO. By streamlining your product development processes, Platflow helps enhance product quality while accelerating innovation and reducing time-to-market. With its intuitive interface and easy-to-use features, Platflow requires minimal training, allowing teams to focus on their core competencies.
Silver Sponsor
Blue Matter Consulting is a strategic consulting firm serving the life sciences industry. Its diverse client base includes more than 250 companies, ranging from start-ups to leading global biopharma companies. The firm helps clients develop strategy and maximize value at the product, portfolio, and organizational levels.
To deliver strategic projects, the firm integrates expertise across critical industry functions (including Business Development, Market Access, Marketing and Sales, and Medical Affairs) with comprehensive capabilities in primary research and data analytics. The firm specializes in corporate and portfolio strategy, as well as commercial strategy for pre-launch and launch-stage therapies. However, it also assists clients with in-line (marketed) products.
Blue Matter performs work in a range of therapeutic areas but offers in-depth expertise in complex markets such as oncology, CNS, and rare diseases. The firm works with the full range of product types, encompassing small molecules and large molecules, including cell and gene therapies.
Strategic Partner
Captario is a software company catering to the pharmaceutical industry. Captario develops SUM® – Strategic Uncertainty Management, a cloud-based modeling & simulation software further empowered by AI and Machine Learning. It enables project and portfolio teams to base strategic decisions on a rich understanding of practically all possible futures.
Associate Partner
Tillotts Pharma AG, part of the Japanese Zeria Group, is a fast-growing specialty pharma company with close to 400 employees in Switzerland and abroad. Tillotts is dedicated to the development, acquisition and commercialization of innovative pharmaceutical products for the digestive system. Tillotts successfully markets its own products for the treatment of IBD and Clostridioides difficile infection (CDI) as well as in-licensed products in around 65 countries through its affiliates within Europe and a network of partners throughout the world.
Event Speakers
Anne Woollett
Clinical Trials Director, TrialHub
Alfred Health
Amanda Mao
Alliance and Project Management Lead
Keros Therapeutics
Chris Quinn
CMC Lead, Head of CMC Science - R&D Plasma Product Development (PPD)
CSL
Debra Bourke
Head of Medical Affairs
Mayne Pharma
Emma Pinkerton
Director, Global Site Management
Abbvie
Fardaad Choksey
Associate Medical Director, Oncology – ANZ
Astrazeneca
Gail Wiggins
Director Project Management
CSL
Jolanta Airey
Chief Medical Officer
Cynata Therapeutics
Jolien Reid
Head of Clinical Operations - Translational Science Hub
Sanofi
Julie Monk
Director of Clinical Development
RAGE Biotech
Industry Pioneers Attending From
Testimonials
REGISTRATION
Conference
Ticket | September 3-4, 2025-
Access to All Conference Sessions of thePharma and Biotech Project, Program and Project Management Conference Australia 2025
-
Access to Post Conferences Networking
-
Conference Materials
-
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch
BECOME A PARTNER
OF this EVENT-
Present on the Main Stage
-
Hold an exhibit at this event
-
Showcase your Brand in Marketing Material
-
Gain exposure through alternative partnership benefits
